ABCG2 and leukemia: Collectively, our data showed that ART potentiated ADR cytotoxicity by inhibiting glycolysis and downregulating mdr1 and abcg2 gene expression in ADR-resistant K562 cells, indicating the values of ART and ADR combined therapy in reducing drug resistance in leukemia and further elucidating the crucial roles of glycolysis in drug resistance.